Docetaxel Ebewe 10 mg/Vial 8ML: Targeted Chemotherapy for Cancer Treatment

Docetaxel Ebewe 10 mg/Vial 8ML is a potent chemotherapy medication used in the treatment of various cancers. This medication, containing the active ingredient Docetaxel, belongs to a class of drugs known as taxoids, which work by interfering with the growth of cancer cells and slowing their spread in the body.

As a critical component of cancer therapy, Docetaxel Ebewe is administered under the strict supervision of a healthcare professional in a clinical setting. It is indicated for the treatment of several types of cancer, including breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

The formulation of Docetaxel Ebewe 10 mg/Vial 8ML is designed for intravenous infusion, ensuring precise delivery of the active substance to target cancer cells throughout the body.

Benefits of Use

• Effective in treating various types of cancer, including advanced or metastatic cases.
• Works by disrupting the cell division process in cancer cells, leading to their destruction.
• Often used in combination with other chemotherapy agents or treatments to enhance efficacy.
• Contributes to improving patient outcomes and quality of life by managing disease progression.

How to Use

1. Docetaxel Ebewe must be prepared and administered by qualified medical personnel.
2. The concentrate in the vial must be diluted with an appropriate solvent before intravenous infusion.
3. The infusion is typically given over a period of approximately one hour.
4. Dosage and treatment schedule are determined by the physician based on the patient's specific cancer type, stage, body surface area, and overall health.
5. Patients should undergo regular monitoring during treatment to assess efficacy and manage potential side effects.

Caution & Warnings

• Docetaxel Ebewe is a hazardous drug and should be handled with care by trained personnel.
• May cause severe adverse reactions, including bone marrow suppression (leading to infections and bleeding), severe hypersensitivity reactions, fluid retention, and neurotoxicity.
• Close medical supervision is required throughout the treatment period.
• Patients should immediately report any unusual symptoms or side effects to their healthcare provider.
• Not recommended for use in pregnant or breastfeeding women due to potential harm to the fetus or infant.
• Individuals with severe liver impairment may require dose adjustments or not be suitable for treatment.
• Avoid concurrent use of certain medications that may interact with Docetaxel; always inform your doctor about all medications you are taking.

Ingredients

• Active Ingredient: Docetaxel 10 mg
• Excipients: Polysorbate 80, Ethanol, and Water for injection (exact formulation may vary, refer to package leaflet).

Product Details

• Product Name: Docetaxel Ebewe 10 mg/Vial 8ML
• Brand: Ebewe
• Manufacturer: Ebewe Pharma (Sandoz)
• Drug Type: Prescription Medication (Chemotherapy)
• Dosage Form: Concentrate for solution for infusion
• Strength: 10 mg Docetaxel per 8ML vial
• Administration Route: Intravenous
• Storage: Store in a refrigerator (2°C - 8°C). Protect from light.